Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

One piece of the Insider Financial article supports what some of us have been posting, that the delay in releasing updated financials is a strategic move to stop further conversions by the debt holder followed by dumping the converted shares on the market.

As the situation stands the note holders collectively have tons of debt they can never collect on unless they incentivize management to commercialize the assets. This is their only hope of repayment because their brokers won’t let them convert shares of an alternate reporting company. That means a deal has to be in the works and once the restructuring is complete the stock should surge as the noteholders will be incentivized to have the stock price move higher so the company can become fully operational again.

I believe at this point GC has the debt holders over a barrel. They are out of shares and can't convert any more. Notice the absolute lack of any dilution over the last 4 weeks. The recent announcement of the Tollovid/Tollovir patent allowance will be followed soon by news of the patents issued, and then the NLC Pharma crowdfunding. The patent protection is a key part of any potential investor interest in funding NLC. Whether or not the note holders strike a deal with Todos as suggested in the article, NLC funding will free up capital to fund trials of Tollovid and Tollovir in Long Covid and perhaps Covid as well.

If my read on what is unfolding here is correct, Todos is about to turn the corner. We're already seeing increased interest and media coverage for Tollovid in Long Covid treatment. Big orders for Tollovid directly impacted the supply for those of us who use it daily. It's always a good idea to keep a few bottles ahead. Once production moves to our TX facility we likely won't encounter supply issues like this again since Todos will control production and not be reliant on a contract manufacturer.

Those who understood what they saw unfolding as the share price was driven into the dirt, and took advantage of that understanding by adding shares at ridiculously low prices, should do well when Todos recovers. I'm keeping the faith, regardless of the efforts of those fine folks here trying to save everyone from investing here. This stock isn't for the weak minded or timid investor. It is for those with the resolve to see it through, and to understand the risk and invest responsibly with some sense (not your nest egg or college fund). And it helps to accept responsibility for one's own decisions, good and bad. This is still a high-risk investment, and many challenges lay ahead, but I'm encouraged by what I've seen over the last few weeks. GLTA